Purpose <p>Music therapy is a beneficial supportive intervention in oncology. However, many patients undergoing cancer treatment face treatment-related physical impairments that limit participation in in-person sessions. This study explores the implementation of a video-based group music therapy intervention for patients undergoing tumour therapy.</p> Methods <p>A mixed-methods, single-arm study was conducted with 40 adult cancer patients. The intervention consisted of eight 90-min video-based group music therapy sessions. Standardized questionnaires and open-ended questions were used pre- and post-intervention. Therapists provided structured feedback after each session. Evaluation was guided by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance).</p> Results <p>Recruitment was efficient, with 40 of 44 screened patients enrolled. Attendance (90.1%) and completion (87.5%) rates were high. Participants rated the intervention as highly helpful (<i>M</i> = 4.77, SD = 0.49), with significant reductions in depression and anxiety (<i>p</i> &lt; 0.001). In their feedback, patients frequently reported shared musical experiences and a sense of emotional closeness as particularly meaningful aspects of the sessions. Therapists observed strong group cohesion despite initial technical challenges. Follow-up data indicated continued use of music in daily life, suggesting lasting impact.</p> Conclusion <p>Video-based group music therapy is a feasible and well-accepted intervention for patients undergoing cancer treatment. It addresses access barriers due to treatment-related physical impairments and supports continuity of care. The intervention showed promising results across RE-AIM dimensions, including symptom relief and integration into everyday life. Further studies should assess efficacy and explore adaptations for specific patient subgroups.</p> Trial registration <p>German Clinical Trials Register (DRKS00032339) (registered August 3, 2023).</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Implementing video-based group music therapy during cancer treatment: insights from a mixed-methods study

  • Miriam Grapp,
  • Charlotte Flock,
  • Hans-Christoph Friederich,
  • Till Johannes Bugaj

摘要

Purpose

Music therapy is a beneficial supportive intervention in oncology. However, many patients undergoing cancer treatment face treatment-related physical impairments that limit participation in in-person sessions. This study explores the implementation of a video-based group music therapy intervention for patients undergoing tumour therapy.

Methods

A mixed-methods, single-arm study was conducted with 40 adult cancer patients. The intervention consisted of eight 90-min video-based group music therapy sessions. Standardized questionnaires and open-ended questions were used pre- and post-intervention. Therapists provided structured feedback after each session. Evaluation was guided by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance).

Results

Recruitment was efficient, with 40 of 44 screened patients enrolled. Attendance (90.1%) and completion (87.5%) rates were high. Participants rated the intervention as highly helpful (M = 4.77, SD = 0.49), with significant reductions in depression and anxiety (p < 0.001). In their feedback, patients frequently reported shared musical experiences and a sense of emotional closeness as particularly meaningful aspects of the sessions. Therapists observed strong group cohesion despite initial technical challenges. Follow-up data indicated continued use of music in daily life, suggesting lasting impact.

Conclusion

Video-based group music therapy is a feasible and well-accepted intervention for patients undergoing cancer treatment. It addresses access barriers due to treatment-related physical impairments and supports continuity of care. The intervention showed promising results across RE-AIM dimensions, including symptom relief and integration into everyday life. Further studies should assess efficacy and explore adaptations for specific patient subgroups.

Trial registration

German Clinical Trials Register (DRKS00032339) (registered August 3, 2023).